Iron deficiency with and without anemia in pregnancy: A scoping review of prevalence and perinatal impact
Open Access
- 24 December 2025
- journal article
- review article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 173 (3) , 1183-1196
Abstract
Background: The prevalence of iron deficiency with anemia and iron deficiency without anemia (IDWA) during pregnancy have not been summarized, and evidence of the direct association of IDWA with adverse perinatal outcomes (APO) are unknown. Objectives: To summarize the prevalence of iron deficiency with and without anemia in pregnancy and determine if there is reported evidence of an effect for IDWA on adverse perinatal outcomes (APO). Search Strategy: Literature search was completed using four electronic databases, with no restrictions on date or language. Selection Criteria: Selected were observational studies, randomized controlled trials (RCTs), systematic reviews, meta‐analyses, narrative reviews on iron deficiency (ID) in pregnancy, published from inception to May 30, 2025. Data Collection and Analysis: Two independent reviewers screened article titles, abstracts, and full texts. The PRISMA guideline for scoping reviews was followed. A narrative summary was performed. Results: A total of 33 studies were included comprising five RCTs, 27 observational studies, and one narrative summary, involving 84 618 pregnant women. The prevalence of ID varied from 1.2%–71.0%; 1.2%–55.6% (IDA), and 1.6%–71.0% (IDWA). Two studies exclusively reported on IDWA and APO. The first study reported on preterm birth (adjusted odds ratio [aOR] 0.9, 95% confidence interval [CI]: 0.6–1.4), stillbirth (aOR 4.0, 95% CI: 1.0–14.3), low birthweight (aOR 0.6, 95% CI: 0.4–1.0), and small for gestational age (aOR 0.8, 95% CI: 0.5–1.2) in IDWA versus iron replete. The second study reported an adjusted birthweight of 3140 g (95% CI: 3067–3213) in IDWA and 3202 g (95% CI: 3164–3240) in iron replete individuals ( P = 0.16). Conclusions: Prevalence of ID varied widely, with substantial variability in biomarkers and diagnostic cut‐offs used in case definition. There were limited studies reporting on IDWA and its association with APO. Further research is needed to establish an association and to inform early screening and determine whether treating IDWA improves perinatal outcomes.Keywords
This publication has 82 references indexed in Scilit:
- Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During PregnancyJAMA, 2024
- Daily oral iron supplementation during pregnancyCochrane Database of Systematic Reviews, 2024
- Iron deficiency anemia among women: An issue of health equityBlood Reviews, 2023
- Maternal factors associated with iron deficiency without anaemia in early pregnancy: ECLIPSES studyAnnals of Hematology, 2023
- Global Prevalence of Anemia in Pregnant Women: A Comprehensive Systematic Review and Meta-AnalysisMaternal and Child Health Journal, 2022
- Maternal first trimester iron status and its association with obstetric and perinatal outcomesArchives of Gynecology and Obstetrics, 2022
- Daily oral iron supplementation during pregnancyCochrane Database of Systematic Reviews, 2015
- Anemia in PregnancyClinics In Laboratory Medicine, 2013
- History of Iron in MedicineBlood Cells, Molecules, and Diseases, 2002
- Serum ferritin levels and their significance in normal full‐term pregnant womenInternational Journal of Gynecology & Obstetrics, 1987